Kezar Life Sciences Inc (KZR)
0.80
0.00 (0.00%)
USD |
NASDAQ |
Apr 25, 11:59
Kezar Life Sciences Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 0.0463 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0463
Minimum
Sep 2023
0.0463
Maximum
Sep 2023
0.0463
Average
0.0463
Median
Sep 2023
Debt to Equity Ratio Benchmarks
| Accuray Inc | 3.667 |
| Tonix Pharmaceuticals Holding Corp | 0.0844 |
| Acumen Pharmaceuticals Inc | -- |
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 221.24M |
| Total Liabilities (Quarterly) | 33.66M |
| Shareholders Equity (Quarterly) | 187.57M |